BMJ 2002;324:1311-1312 ( 1 June )

Primary care

Off label prescribing to children in primary care in Germany: retrospective cohort study

Editorial by Banner and pp 1312, 1313

Reinhild Bücheler, specialist in internal medicine and social medicine aMatthias Schwab, senior registrar in clinical pharmacology and paediatrician bKlaus Mörike, lecturer in clinical pharmacology aBernhard Kalchthaler, IT engineer cHartmut Mohr, pharmacist cHelmut Schröder, head of the German drug index dPeter Schwoerer, head cChristoph H Gleiter, professor in clinical pharmacology a

a Division of Clinical Pharmacology, University Hospital Tübingen, D-72076 Tübingen, Germany, b Dr Margarete Fischer-Bosch Institut für Klinische Pharmakologie, D-70376 Stuttgart, Germany, c Medizinischer Dienst der Krankenversicherung Baden-Württemberg, D-77933 Lahr, Germany, d Wissenschaftliches Institut der AOK (Allgemeine Ortskrankenkasse), D-53177 Bonn, Germany

Correspondence to: C H Gleiter christoph.gleiter@med.uni-tuebingen.de

The first 150 words of the full text of this article appear below.

Between 35% and 90% of the drugs prescribed to hospitalised children are either not licensed for children's use or are prescribed outside the terms of their product licence (off label prescribing). 1 2 Subsequent adverse reactions are more likely than with licensed products (6.0% v 3.9%).3 We analysed the extent of prescribing off labelled products in a representative cohort of children in primary care.


    Patients, methods, and results

We used the electronic database of prescriptions of Allgemeine Ortskrankenkasse, Baden-Württemberg. This health insurer covers more than four million people, 42% of the total population of the state. We retrospectively reviewed 1.74 million anonymous prescriptions written by 6886 office based doctors---specialists in paediatric, general, or internal medicine---between 1 January and 31 March 1999 for 455 661 patients aged 0-16 years.


Table Removed (Available Only in the Full Text)

Each prescription was represented by a numerical code, describing the drug's brand name, generic name, formulation, and content per dose unit. Our database did not contain diagnoses, dosage recommendations, or individually prepared . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Prescribing in children must improve
BMJ 2002 324: 0. [Full Text]

Off label prescribing in children
William Banner, Jr
BMJ 2002 324: 1290-1291. [Extract] [Full Text] [PDF]

Unlicensed and off label drug use by children in the community: cross sectional study
Eric Schirm, Hilde Tobi, and Lolkje T W de Jong-van den Berg
BMJ 2002 324: 1312-1313. [Extract] [Full Text] [PDF]

Unlicensed and off label prescription of drugs to children: population based cohort study
Geert W `t Jong, Ingo A Eland, Miriam C J M Sturkenboom, John N van den Anker, and Bruno H Ch Stricker
BMJ 2002 324: 1313-1314. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Baldwin, D. S., Kosky, N. (2007). Off-label prescribing in psychiatric practice. Adv. Psychiatr. Treat. 13: 414-422 [Abstract] [Full text]  
  • Zuppa, A. F., Adamson, P. C., Mondick, J. T., Davis, L. A., Maka, D. A., Narayan, M., Nicholson, C., Patel, D., Collison, K. R., Barrett, J. S. (2005). Drug Utilization in the Pediatric Intensive Care Unit: Monitoring Prescribing Trends and Establishing Prioritization of Pharmacotherapeutic Evaluation of Critically Ill Children. J Clin Pharmacol 45: 1305-1312 [Abstract] [Full text]  
  • Hill, P (2005). Off licence and off label prescribing in children: litigation fears for physicians. Arch. Dis. Child. 90: i17-i18 [Abstract] [Full text]  
  • Nunn, A J (2003). Making medicines that children can take. Arch. Dis. Child. 88: 369-371 [Full text]  
  • Boos, J. (2003). Off label use--label off use?. Ann Oncol 14: 1-5 [Full text]  
  • O'Donnell, C. P. F., Stone, R. J., Morley, C. J. (2002). Unlicensed and Off-Label Drug Use in an Australian Neonatal Intensive Care Unit. Pediatrics 110: e52-52 [Abstract] [Full text]  
  • Steinbrook, R. (2002). Testing Medications in Children. NEJM 347: 1462-1470 [Full text]  
  • Guiton, S, Reith, D. M, Isitt, V. L (2002). Off label prescribing in children. BMJ 325: 338-338 [Full text]  
  • Banner, W. Jr (2002). Off label prescribing in children. BMJ 324: 1290-1291 [Full text]  

Rapid Responses:

Read all Rapid Responses

Paediatric off label prescribing in Germany
Thomas Boehler
bmj.com, 6 Jun 2002 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ